Literature DB >> 11044086

Ras-GAP binding and phosphorylation by herpes simplex virus type 2 RR1 PK (ICP10) and activation of the Ras/MEK/MAPK mitogenic pathway are required for timely onset of virus growth.

C C Smith1, J Nelson, L Aurelian, M Gober, B B Goswami.   

Abstract

We used a herpes simplex virus type 2 (HSV-2) mutant with a deletion in the RR1 (ICP10) PK domain (ICP10DeltaPK) and an MEK inhibitor (PD98059) to examine the role of ICP10 PK in virus growth. In HSV-2-infected cells, ICP10 PK binds and phosphorylates the GTPase activating protein Ras-GAP. In vitro binding and peptide competition assays indicated that Ras-GAP N-SH2 and PH domains, respectively, bind ICP10 at phosphothreonines 117 and 141 and a WD40-like motif at positions 160 to 173. Binding and phosphorylation did not occur in cells infected with ICP10DeltaPK. GTPase activity was significantly lower in HSV-2- than in ICP10DeltaPK-infected cells. Conversely, the levels of activated Ras and mitogen-activated protein kinase (MAPK), and the expression and stabilization of the transcription factor c-Fos were significantly increased in cells infected with HSV-2 or a revertant virus [HSV-2(R)] but not with ICP10DeltaPK. PD98059 inhibited MAPK activation and induction-stabilization of c-Fos. Expression from the ICP10 promoter was increased in cells infected with HSV-2 but not with ICP10DeltaPK, and increased expression was ablated by PD98059. ICP10 DNA formed a complex with nuclear extracts from HSV-2-infected cells which was supershifted by c-Fos antibody and was not seen with extracts from ICP10DeltaPK-infected cells. Complex formation was abrogated by PD98059. Onset of HSV-2 replication was significantly delayed by PD98059 (14 h versus 2 h in untreated cells), a delay similar to that seen for ICP10DeltaPK. The data indicate that Ras-GAP phosphorylation by ICP10 PK is involved in the activation of the Ras/MEK/MAPK mitogenic pathway and c-Fos induction and stabilization. This results in increased ICP10 expression and the timely onset of HSV-2 growth.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 11044086      PMCID: PMC110916          DOI: 10.1128/jvi.74.22.10417-10429.2000

Source DB:  PubMed          Journal:  J Virol        ISSN: 0022-538X            Impact factor:   5.103


  88 in total

1.  A novel human gene similar to the protein kinase (PK) coding domain of the large subunit of herpes simplex virus type 2 ribonucleotide reductase (ICP10) codes for a serine-threonine PK and is expressed in melanoma cells.

Authors:  C C Smith; Y X Yu; M Kulka; L Aurelian
Journal:  J Biol Chem       Date:  2000-08-18       Impact factor: 5.157

2.  Protein kinase C forms a complex with and phosphorylates the GTPase activating protein GAP: phosphorylation by PKC is dependent on tyrosine phosphorylation of GAP and/or a GAP-associated protein.

Authors:  M Gschwendt; W Kittstein; F Marks
Journal:  Biochem Biophys Res Commun       Date:  1993-07-15       Impact factor: 3.575

Review 3.  Mitogen-activated protein kinase pathways.

Authors:  M J Robinson; M H Cobb
Journal:  Curr Opin Cell Biol       Date:  1997-04       Impact factor: 8.382

Review 4.  Signal transduction from multiple Ras effectors.

Authors:  M E Katz; F McCormick
Journal:  Curr Opin Genet Dev       Date:  1997-02       Impact factor: 5.578

5.  The large subunit of herpes simplex virus type 2 ribonucleotide reductase (ICP10) is associated with the virion tegument and has PK activity.

Authors:  C C Smith; L Aurelian
Journal:  Virology       Date:  1997-08-04       Impact factor: 3.616

Review 6.  ras GTPase activating protein: signal transmitter and signal terminator.

Authors:  F McCormick
Journal:  Cell       Date:  1989-01-13       Impact factor: 41.582

7.  Guanine-nucleotide-releasing factor hSos1 binds to Grb2 and links receptor tyrosine kinases to Ras signalling.

Authors:  N Li; A Batzer; R Daly; V Yajnik; E Skolnik; P Chardin; D Bar-Sagi; B Margolis; J Schlessinger
Journal:  Nature       Date:  1993-05-06       Impact factor: 49.962

Review 8.  Herpes simplex virus type 2: unique biological properties include neoplastic potential mediated by the PK domain of the large subunit of ribonucleotide reductase.

Authors:  L Aurelian
Journal:  Front Biosci       Date:  1998-02-15

9.  The jun and fos protein families are both required for cell cycle progression in fibroblasts.

Authors:  K Kovary; R Bravo
Journal:  Mol Cell Biol       Date:  1991-09       Impact factor: 4.272

10.  The Mos/MAP kinase pathway stabilizes c-Fos by phosphorylation and augments its transforming activity in NIH 3T3 cells.

Authors:  K Okazaki; N Sagata
Journal:  EMBO J       Date:  1995-10-16       Impact factor: 11.598

View more
  41 in total

1.  Performance and use of a ribonucleotide reductase herpes simplex virus type-specific serological assay.

Authors:  S Q Wales; C C Smith; M Wachsman; G Calton; L Aurelian
Journal:  Clin Diagn Lab Immunol       Date:  2004-01

2.  Quantitative proteomic analyses of influenza virus-infected cultured human lung cells.

Authors:  Kevin M Coombs; Alicia Berard; Wanhong Xu; Oleg Krokhin; Xiaobo Meng; John P Cortens; Darwyn Kobasa; John Wilkins; Earl G Brown
Journal:  J Virol       Date:  2010-08-11       Impact factor: 5.103

3.  The growth compromised HSV-2 mutant DeltaRR prevents kainic acid-induced apoptosis and loss of function in organotypic hippocampal cultures.

Authors:  Michael D Gober; Jennifer M Laing; Scott M Thompson; Laure Aurelian
Journal:  Brain Res       Date:  2006-10-03       Impact factor: 3.252

4.  Visna virus-induced activation of MAPK is required for virus replication and correlates with virus-induced neuropathology.

Authors:  Sheila A Barber; Linda Bruett; Brian R Douglass; David S Herbst; M Christine Zink; Janice E Clements
Journal:  J Virol       Date:  2002-01       Impact factor: 5.103

Review 5.  Oncolytic virotherapy for pancreatic cancer.

Authors:  Sonia Wennier; Shoudong Li; Grant McFadden
Journal:  Expert Rev Mol Med       Date:  2011-05-18       Impact factor: 5.600

6.  Oncolytic virotherapy for ovarian cancer.

Authors:  Shoudong Li; Jessica Tong; Masmudur M Rahman; Trevor G Shepherd; Grant McFadden
Journal:  Oncolytic Virother       Date:  2012-08

Review 7.  The oncolytic virus ΔPK has multimodal anti-tumor activity.

Authors:  Laure Aurelian; Dominique Bollino; Aric Colunga
Journal:  Pathog Dis       Date:  2016-05-29       Impact factor: 3.166

8.  Localization of ERK/MAP kinase is regulated by the alphaherpesvirus tegument protein Us2.

Authors:  Mathew G Lyman; Jessica A Randall; Christine M Calton; Bruce W Banfield
Journal:  J Virol       Date:  2006-07       Impact factor: 5.103

9.  The HSV-2 protein ICP10PK prevents neuronal apoptosis and loss of function in an in vivo model of neurodegeneration associated with glutamate excitotoxicity.

Authors:  Erin K Golembewski; Samantha Q Wales; Laure Aurelian; Paul J Yarowsky
Journal:  Exp Neurol       Date:  2006-10-16       Impact factor: 5.330

10.  The herpes simplex virus type 2 gene ICP10PK protects from apoptosis caused by nerve growth factor deprivation through inhibition of caspase-3 activation and XIAP up-regulation.

Authors:  Samantha Q Wales; Baiquan Li; Jennifer M Laing; Laure Aurelian
Journal:  J Neurochem       Date:  2007-10       Impact factor: 5.372

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.